The Journal of Rheumatology, 0315-162X

Journal

  1. 2019
  2. 2017
  3. 2016
  4. Voshaar, M. O., van Onna, M., van Genderen, S., van de laar, M., van der Heijde, D., Heuft, L., ... Boonen, A. (2016). Development and Validation of a Short Form of the Social Role Participation Questionnaire in Patients with Ankylosing Spondylitis. The Journal of Rheumatology, 43(7), 1386-1392. https://doi.org/10.3899/jrheum.151013
  5. 2015
  6. de Rooy, D. P. C., Tsonaka, R., Andersson, M. L. E., Forslind, K., Zhernakova, A., Frank-Bertoncelj, M., ... van der Helm-van Mil, A. H. M. (2015). Genetic Factors for the Severity of ACPA-negative Rheumatoid Arthritis in 2 Cohorts of Early Disease: A Genome-wide Study. The Journal of Rheumatology, 42(8), 1383-1391. https://doi.org/10.3899/jrheum.140741
  7. 2014
  8. 2013
  9. 2011
  10. Martin, J-E., Alizadeh, B. Z., Gonzalez-Gay, M. A., Balsa, A., Pascual-Salcedo, D., Gonzalez-Escribano, M. F., ... Martin, J. (2011). Evidence for PTPN22 R620W Polymorphism As the Sole Common Risk Variant for Rheumatoid Arthritis in the 1p13.2 Region. Journal of Rheumatology, 38(11), 2290-2296. https://doi.org/10.3899/jrheum.110361
  11. Bieleman, H. J., Bierma-Zeinstra, S. M. A., Oosterveld, F. G. J., Reneman, M. F., Verhagen, A. P., & Groothoff, J. W. (2011). The Effect of Osteoarthritis of the Hip or Knee on Work Participation. Journal of Rheumatology, 38(9), 1835-1843. https://doi.org/10.3899/jrheum.101210
  12. van Dijken, T. D., Vastert, S. J., Gerloni, V. M., Pontikaki, I., Linnemann, K., Girschick, H., ... Wulffraat, N. M. (2011). Development of Inflammatory Bowel Disease in Patients with Juvenile Idiopathic Arthritis Treated with Etanercept. Journal of Rheumatology, 38(7), 1441-1446. https://doi.org/10.3899/jrheum.100809
  13. 2010
  14. Otten, M. H., Prince, F. H. M., Twilt, M., van Rossum, M. A. J., Armbrust, W., Hoppenreijs, E. P. A. H., ... van Suijlekom-Smit, L. W. A. (2010). Delayed clinical response in patients with juvenile idiopathic arthritis treated with etanercept. Journal of Rheumatology, 37(3), 665-667. https://doi.org/10.3899/jrheum.090550
  15. 2008
  16. 2007
  17. Grootscholten, C., Snoek, F. J., Bijl, M., van Houwelingen, H. C., Derksen, R. H. W. M., Berden, J. H. M., & null, null (2007). Health-related quality of life and treatment burden in patients with proliferative lupus nephritis treated with cyclophosphamide or azathioprine/methylprednisolone in a randomized controlled trial. Journal of Rheumatology, 34(8), 1699-1707.
  18. Seo, P., Luqmani, R. A., Flossmann, O., Hellmich, B., Herlyn, K., Hoffman, G. S., ... Merkel, P. A. (2007). The future of damage assessment in vasculitis. Journal of Rheumatology, 34(6), 1357-1371.
  19. Jacobs, J. W. G., de Nijs, R. N. J., Lems, W. F., Geusens, P. P. M. M., Laan, R. F. J., Huisman, A-M., ... Bijlsma, J. W. J. (2007). Prevention of glucocorticoid induced osteoporosis with alendronate or alfacalcidol: Relations of change in bone mineral density, bone markers, and calcium homeostasis. Journal of Rheumatology, 34(5), 1051-1057.
  20. 2006
  21. Hoekstra, M., Haagsma, C., Neef, C., Proost, J., Knuif, A., & van de Laar, M. (2006). Splitting high-dose oral methotrexate improves bioavailability: A pharmacokinetic study in patients with rheumatoid arthritis. Journal of Rheumatology, 33(3), 481-485.
  22. 2005
  23. Merkel, PA., Seo, P., Aries, P., Neogi, T., Villa-Forte, A., Cuthbertson, D., ... Vasculitis Clinical Res Consortium (2005). Current status of outcome measures in vasculitis: Focus on Wegener's granulomatosis and microscopic polyangiitis. Report from OMERACT 7. Journal of Rheumatology, 32(12), 2488-2495.
  24. Sharp, JI., van der Heijde, D., Angwin, J., Duryea, J., Moens, HJB., Jacobs, JWG., ... Strand, CV. (2005). Measurement of joint space width and erosion size. Journal of Rheumatology, 32(12), 2456-2461.
  25. Vriezekolk, JE., Geenen, R., Hartkamp, A., Godaert, GLR., Bootsma, H., Kruize, AA., ... Derksen, RHWM. (2005). Psychological and somatic predictors of perceived and measured ocular dryness of patients with primary Sjogren's syndrome. Journal of Rheumatology, 32(12), 2351-2355.
  26. Van Roon, E. N., Van De Laar, M. A. F. J., Janssen, M., Kruijsen, M. W. M., Jansen, T. L. T. A., & Brouwers, J. R. B. J. (2005). Parenteral gold preparations. Efficacy and safety of therapy after switching from aurothioglucose to aurothiomalate. Journal of Rheumatology, 32(6), 1026-1030.
  27. Van den Brande, JMH., Hommes, DW., & Peppelenbosch, MP. (2005). Infliximab induced T lymphocyte apoptosis in Crohn's disease. Journal of Rheumatology, 32, 26-30.
  28. Derksen, WJM., Erkan, D., Potter, HG., & Lockshin, MD. (2005). Interferon induced digital artery vasculitis. Journal of Rheumatology, 32(1), 191-192.
  29. 2004
  30. Hoekstra, M., Haagsma, C., Neef, C., Proost, J. H., Knuif, A., & van der Laar, M. (2004). Bioavailability of higher dose methotrexate comparing oral and subcutaneous administration in patients with rheumatoid arthritis. Journal of Rheumatology, 31(4), 645 - 648.
  31. 2003
  32. 2002
  33. Kalk, WWI., Mansour, K., Vissink, A., Spijkervet, FKL., Bootsma, H., Kallenberg, CGM., ... Amerongen, AVN. (2002). Oral and ocular manifestations in Sjogren's syndrome. Journal of Rheumatology, 29(5), 924-930.
Previous 1 2 Next

ID: 1263570